Position in ROIV
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$489,797
-$290,345 QoQ
Shares Held
13,840
-50.9% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#285
of 494 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ROIV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Private Advisor Group, LLC holds $44,247,243 across 48 Biotechnology names. ROIV ranks #20 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
18,557 | $11,571,031 | |
| 2 | CRSP |
CRISPR Therapeutics AG
|
111,129 | $6,060,975 | |
| 3 | CRMD |
CorMedix Inc.
|
415,406 | $3,260,937 | |
| 4 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
30,352 | $2,473,991 | |
| 5 | TLX |
Telix Pharmaceuticals Ltd
|
197,250 | $2,274,292 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4,130 | $2,051,494 | |
| 7 | IBRX |
ImmunityBio, Inc.
|
165,954 | $1,452,927 | |
| 8 | AVXL |
Anavex Life Sciences Corp.
|
504,000 | $1,305,360 |
All Filings in ROIV
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $489,797 | 13,840 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $780,142 | 28,164 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $259,206 | 11,945 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $308,213 | 20,371 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $165,894 | 14,720 | Shares | Sole | 2025-08-11 | |
| No filing history on record for this holder in this stock. | ||||||